Drugs / Dextrose 5% in water
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06308887 Comparator | Oct 2023 → Feb 2024 | chronic pain syndrome, osteoarthritis, knee | Kastamonu University | Completed | No outcome recorded |
| — | NCT04579783 Comparator | Nov 2020 → Oct 2022 | carpal tunnel syndrome | National Taiwan University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dextrose 5% in water | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06308887 ↗ |
| Route | Other | “Repeated ultrasound guided injection intracarpal median nerve hydro-dissection with 5 mL 5% dextrose (Group B) or 5mL triamcinolone acetonide injection (Group A) in patients with CTS” NCT04579783 ↗ |